Editorial · 30 May 2021
Research articlePublished 10 Nov 2010
Citalopram in the treatment of depressive disorders: An open label, multicenter study in China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
that this agent is safe and effective for the treatment of depressive disorders. We investigated the safety and efficacy of citalopram in the treatment of Chinese patients with depressive disorders. An 8-week, open-label, multicenter study evaluated the safety and efficacy of citalopram in the treatment of patients with an ICD-10 diagnosis of depressive disorder or depressive episode of bipolar disorder. Efficacy measures included the Hamilton Rating Scale for Depression (HAMD) and the Clinical Global Impression (CGI). A total of 6080 patients (2553 men, 3527 women) (mean age 40.9 ± 15.6 years, range 18 – 92) participated in the study. Mean HAMD scores decreased significantly (p<0.001) after 2 weeks of treatment and at all subsequent study visits. Endpoint analyses showed that 89.9% of the patients demonstrated a clinical response, defined as a 50% reduction in HAMD scores. The mean daily dose of citalopram at endpoint was 23.65 mg. Nausea (7.6%), headache (3.7%) and dry mouth (2.9%) were the most frequently reported adverse events. Patients with bipolar depression and comorbid obsessive compulsive disorder (OCD) received a higher mean daily dose (26.4 and 27.7 mg, respectively), while patients with comorbid physical disorders received a lower dose (21.9 mg) than patients with simple depressive disorder. The results of this 8-week open-label study suggest that citalopram is safe and effective in the treatment of depression in Chinese patients. Limitations is an open-label and uncontrolled.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Pharmacy and Pharmacology.
Editorial · 28 May 2021
Nuclear Medicine : A New Aspect In Medicine
Editorial · 24 May 2021
The journal of pharmacy and pharmacology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Pharmacy and Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Tianmei Si”
- BylineArticles whose byline prints “Liang Shu”